Discover 26 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 26
Active & Responsive
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Hattiesburg MS, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase2, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Hattiesburg MS, Germantown TN, Atlanta GA, Nashville TN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05827016
Phase3, Recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
for
Preclinical Alzheimer's Disease
Location: Hattiesburg MS, Jacksonville FL, The Villages FL,
Sponsor: Janssen Pharmaceutica N.V., Belgium
Sex: All
Age: 55 - 70+
Code: NCT06544616
Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Hattiesburg MS, New Orleans LA, Jonesboro AR,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)